Cijiang He
Icahn School of Medicine at Mount Sinai
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Cijiang He.
Journal of The American Society of Nephrology | 2003
Jaime Uribarri; Melpomeni Peppa; Weijing Cai; Teresia Goldberg; Min Lu; Cijiang He; Helen Vlassara
Advanced glycation endproduct (AGE) levels are elevated in renal failure patients and may contribute to the excessive cardiovascular disease in this population. Diet-derived AGE are major contributors to the total body AGE pool. It was postulated that a reduction in dietary AGE intake might impact on the high circulating AGE levels in renal failure patients. Twenty-six nondiabetic renal failure patients on maintenance peritoneal dialysis were randomized to either a high or a low AGE diet for 4 wk. Three-day dietary records, fasting blood, 24-h urine, and dialysis fluid collections were obtained at baseline and end of study. AGE levels were determined by ELISA for N(epsilon)-carboxymethyl-lysine (CML) and methylglyoxal-derivatives (MG). Eighteen patients completed the study. Low dietary AGE intake decreased serum CML (34%; P < 0.002), serum MG (35%; P < 0.008), CML-LDL (28%; P < 0.011), CML-apoB (25%; P < 0.028), dialysate CML (39%; P < 0.03), and dialysate MG output (40%; P < 0.04). High dietary AGE intake increased serum CML (29%; P < 0.028), serum MG (26%; P < 0.09), CML-LDL (50%; P < 0.011), CML-apoB (67%; P < 0.028), and dialysate CML output (27%; P < 0.01). Serum AGE correlated with BUN (r = 0.6, P < 0.002 for CML; r = 0.4, P < 0.05 for MG), serum creatinine (r = 0.76, P < 0.05 for CML; r = 0.55, P < 0.004 for MG), total protein (r = 0.4, P < 0.05 for CML; r = 0.4, P < 0.05 for MG), albumin (r = 0.4, P < 0.02 for CML; r = 0.4, P < 0.05 for MG), and phosphorus (r = 0.5, P < 0.006 for CML; r = 0.5, P < 0.01 for MG). It is concluded that dietary glycotoxins contribute significantly to the elevated AGE levels in renal failure patients. Moreover, dietary restriction of AGE is an effective and feasible method to reduce excess toxic AGE and possibly cardiovascular associated mortality.
Molecular Medicine | 2002
Weijing Cai; Qiao-di Gao; Li Zhu; Melpomeni Peppa; Cijiang He; Helen Vlassara
BackgroundThe general increase in reactive oxygen species generated from glucose-derived advanced glycation endproducts (AGEs) is among the key mechanisms implicated in tissue injury due to diabetes. AGE-rich foods could exacerbate diabetic injury, at least by raising the endogenous AGE.Materials and MethodsHerein, we tested whether, prior to ingestion, diet-derived AGEs contain species with cell activating (TNFα), chemical (cross-linking) or cell oxidative properties, similar to native AGEs. Glutathione (GSH) and GSH peroxidase (GPx) were assessed after exposure of human umbilical vein endothelial cell (HUVECs) to affinity-purified food-AGE extracts, each exposed to 250°C, for 10 min, along with synthetic AGEs.ResultsAnimal product-derived AGE, like synthetic methylglyoxal-bovine serum albumin (MG-BSA), AGE-BSA, and AGE-low density lipoprotein (AGE-LDL), induced a dose- and time-dependent depletion of GSH (↓60–75%, p < 0.01) and an increase in GPx activity (↑500–600%, p < 0.01), consistent with marked TNFα and cross-link formation (p < 0.05); this contrasted with the low bioreactivity of starch/vegetable AGE-extracts, which was similar to that of control BSA and CML-BSA and BSA (p:NS). Anti-AGE-R1,2,3 and —RAGE IgG each inhibited cell-associated 125I-dAGE by ∼30–55%; GSH/GPx were effectively blocked by N-acetyl-cysteine (NAC, 800 uM, p < 0.01) and aminoguanidine-HCl (AG, 100uM, p < 0.01).ConclusionThus, food-derived AGE, prior to absorption, contain potent carbonyl species, that can induce oxidative stress and promote inflammatory signals.
Diabetes-metabolism Research and Reviews | 2002
Feng Zheng; Cijiang He; Weijing Cai; Masakazu Hattori; Michael W. Steffes; Helen Vlassara
An Erratum has been published for this article in Diabetes Metabolism Research and Reviews 18(4) 2002, 332.
Diabetes-metabolism Research and Reviews | 2002
Feng Zheng; Cijiang He; Weijing Cai; Masakazu Hattori; Michael W. Steffes; Helen Vlassara
The original article to which this Erratum refers was published Diabetes/Metabolism Research Reviews 18(3) 2002, 224–237. Copyright
Proceedings of the National Academy of Sciences of the United States of America | 1997
Theodore Koschinsky; Cijiang He; Tomoko Mitsuhashi; Richard Bucala; Cecilia Liu; Christina Buenting; Kirsten Heitmann; Helen Vlassara
Proceedings of the National Academy of Sciences of the United States of America | 1996
Yong Ming Li; Tomoko Mitsuhashi; D. Wojciechowicz; N. Shimizu; J. Li; A. Stitt; Cijiang He; D. Banerjee; Helen Vlassara
Diabetes | 1999
Cijiang He; J. Sabol; Tomoko Mitsuhashi; Helen Vlassara
Diabetes | 2003
Melpomeni Peppa; Cijiang He; Masakazu Hattori; Robert McEvoy; Feng Zheng; Helen Vlassara
Journal of The American Society of Nephrology | 1995
Chih-Wei Yang; Masakazu Hattori; Helen Vlassara; Cijiang He; Michael A. Carome; Eiji Yamato; Sharon J. Elliot; Gary E. Striker; Liliane J. Striker
Molecular Medicine | 2001
Cijiang He; Theodore Koschinsky; Christina Buenting; Helen Vlassara